Delivery Order SPE2DB22D3016-SPE2DB24FAXC2
Award Date 5/31/24
Potential Completion Date 6/24/24
Potential Value $24K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product VYVGART 400 MG/20 ML VIAL 20ML. The $24,310.92 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $48,621.84 to provide VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products. This contract has a completion date of March 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award. This delivery order contract is issued under a larger indefinite delivery contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $8,103.66 firm fixed price delivery order is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a completion date of March 8, 2024 and was awarded on February 15, 2024. This award is part of Amerisourcebergen Drug Corp's broader role as the prime contractor on...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, for the supply of VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products. The contract has a potential value of $16,207.28 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award and serves as a supplier of pharmaceuticals and medical supplies to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $23,976.78 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) for 400 mg/20 ml vials of the pharmaceutical product VYVGART. This delivery order has a completion date of November 17, 2023. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. The company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $16,207.28 firm fixed price delivery order is for the supply of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) issued by DLA to Amerisourcebergen Drug Corp, with a potential value of...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product, with a potential value of $8,103.66. The contract has a completion date of March 13, 2024. Amerisourcebergen Drug Corp has also been awarded an Indefinite Delivery Contract (IDC) by DLA to provide a comprehensive range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract has a potential value of $8,103.66 and a completion date of March 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of VYVGART 400 mg/20 ml vials totaling $12,792.51 with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's substantial...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,113.36, is for the provision of VYVGART 400 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAXC2Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVGART 400 MG/20 ML VIAL 20ML pharmaceutical products to the Defense Logistics Agency (DLA). The $24,310.92 firm fixed-price delivery order contract has a completion date of June 24, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025 with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This order is not associated with a set-aside designation.
Generated 8/30/24, 7:15 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.3k | 5/31/24 |